Search results
Recent Insider Activity Could Benefit AMGEN Inc.
Knox Daily· 2 days agoAs a result of the transaction, Graham Jonathan P now holds 28,078 shares, worth roughly $8.84 million. William Blair upgraded its AMGEN Inc. [AMGN] rating ...
The Art of Valuation: Discovering Amgen Inc's Intrinsic Value
Guru Focus· 4 days agoIn this article, we will take a look into Amgen Inc's (AMGN) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of usi
Amgen Inc. (NASDAQ:AMGN) Holdings Cut by Panagora Asset Management Inc.
ETF DAILY NEWS· 4 days agoPanagora Asset Management Inc. decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.1% in the fourth quarter ...
Supreme Court Holds Invalid Cholesterol Drug Patent That Covered Millions of Undisclosed Antibodies...
JD Supra· 2 days agoIn Amgen Inc. v. Sanofi,1 the Supreme Court unanimously held that “[i]f a patent claims an entire class of processes, machines, manufactures, or compositions ...
Amgen shares hold as FDA approves Imdelltra ahead of schedule By Investing.com
Investing.com· 6 days agoThe FDA's decision came approximately one month prior to the anticipated Prescription Drug User Fee...
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like...
Benzinga· 2 days agoRoundhill Investments launched a new exchange-traded fund (ETF) Tuesday. What Happened: The...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 8 hours agoCHS-114 shown to have an acceptable safety profile with no dose-limiting toxicities (DLTs) in heavily pretreated patients with solid tumors Selective depletion of peripheral CCR8+ regulatory T cells (Tregs) was observed and depletion was maintained
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
CNBC· 3 days agoThe Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai,...